بررسی سطح خونی هورمون لپتین قبل و بعد از درمان با متفورمین در بیماران دیابتی نوع ΙΙ(NIDDM)

Authors

  • افخمی اردکانی, محمد
  • دیده دار , رضا
Abstract:

Introduction: Leptin is a fat tissue hormone that has 176 amino acids with a molecular weight of 16 KD . Leptin has effects on the hypothalamus and peripheral tissues resulting in decreased food absorption and increased energy consumption that finally reduces the body weight and BMI. The aim of this research was to investigate the blood levels of leptin before and after treatment with Metformin in type II diabetic patients. Methods: 25 type II diabetic patients without any previous drug treatment history were investigated. This study was a clinical trail before and after treatment with Metformin. Results: There was no particular difference in BMI, average body weight, fat mass and free fat mass before and after treatment. Similarly, the difference in concentration levels of blood glucose, cholesterol, tri-glycerides and LDL-cholesterol before and after treatment was not statistically significant. Also, there was no difference in the average concentration of leptin and insulin before and after treatment Conclusion: This result showed that although metformin decreased glucose and lipid levels during the treatment period, (1 month) it did not have an effect on leptin, Insulin and other related factors during treatment.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

بررسی سطح خونی هورمون لپتین قبل و بعد از درمان با متفورمین در بیماران دیابتی نوع ιι(niddm)

مقدمه: لپتین هورمون بافت چربی با 176 اسید آمینه و 16 کیلو دالتون وزن مولکولی است. لپتین با اثر بر هیپوتالاموس و بافت های محیطی بدن باعث کاهش جذب غذا و افزایش مصرف انرژی شده و در نهایت وزن بدن و bmi ( body mass index)تنظیم می شود. هدف این مطالعه بررسی سطح خونی هورمون لپتین قبل و بعد از درمان با متفورمین در بیماران دیابتی نوع ιι است. روش بررسی: 25 بیمار دیابتی نوع ιι بدون مصرف هیچ دارویی جهت بررس...

full text

اثر بربرین در تنظیم آستروسیتهای Gfap+ ناحیه هیپوکمپ موشهای صحرایی دیابتی شده با استرپتوزوتوسین

Background: Diabetes mellitus increases the risk of central nervous system (CNS) disorders such as stroke, seizures, dementia, and cognitive impairment. Berberine, a natural isoquinolne alkaloid, is reported to exhibit beneficial effect in various neurodegenerative and neuropsychiatric disorders. Moreover astrocytes are proving critical for normal CNS function, and alterations in their activity...

full text

اثر بربرین در تنظیم آستروسیتهای Gfap+ ناحیه هیپوکمپ موشهای صحرایی دیابتی شده با استرپتوزوتوسین

Background: Diabetes mellitus increases the risk of central nervous system (CNS) disorders such as stroke, seizures, dementia, and cognitive impairment. Berberine, a natural isoquinolne alkaloid, is reported to exhibit beneficial effect in various neurodegenerative and neuropsychiatric disorders. Moreover astrocytes are proving critical for normal CNS function, and alterations in their activity...

full text

مقایسه سطح خونی هورمون لپتین در بیماران چاق دیابتی و غیردیابتی

Introduction: Leptin was first discovered from the "Ob Gene" by Friedwan and co-workers in 1994. It is a small peptide with 167 amino acids and molecular weight of 16 Kd . It is secreted by adipose tissues. Leptin has two type of receptors in Hypothalamus and other tissues including muscles, liver and intestines. Leptin inhibits neuropeptide Y resulting in decreased appetite and on the other ha...

full text

تاثیر مت فورمین بر سطح خونی هورمون لپتین و انسولین

Background and purpose : Leptin and insulin are secreted from fat and Pancrease tissues respectively. They decrease food consumption and regulate homeostasis of body weight via central nervous system. Metformin is an anti hyperglycemia which is used for treatment of type 2 diabetes. The aim of this study was investigating correlation between leptin and insulin levels before and after treatemn...

full text

اثر متفورمین در کنترل قند خون بیماران دیابتی نوع دوم تحت درمان با انسولین

Background: Patients with type 2 diabetes are often obese and require large dose of insulin to achieve glycemic control. Insulin therapy often cause weight gain and results in increasing insulin requirements. This study was conducted to evaluate the efficacy of metformin in combination with insulin in patients with type 2 diabetes poorly controlled with insulin therapy alone. Materials and Meth...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 13  issue 1

pages  3- 7

publication date 2005-04

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023